|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
1
|
Resverlogix Corp.
|
Dec 22, 2020 10:00AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 04:37PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
4
|
Resverlogix Corp.
|
Oct 14, 2020 06:23PM
|
|
Re: Resverlogix Announces Private Placement
|
2
|
Resverlogix Corp.
|
Aug 15, 2020 12:02PM
|
|
Re: Resverlogix Announces Private Placement
|
5
|
Resverlogix Corp.
|
Aug 15, 2020 01:43PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
7
|
Resverlogix Corp.
|
Apr 01, 2020 12:14PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
6
|
Resverlogix Corp.
|
Mar 31, 2020 10:00AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
7
|
Resverlogix Corp.
|
Jun 22, 2022 11:42AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
4
|
Resverlogix Corp.
|
Jun 22, 2022 11:58AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
8
|
Resverlogix Corp.
|
Jun 22, 2022 12:23PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
4
|
Resverlogix Corp.
|
Jun 22, 2022 01:50PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
7
|
Resverlogix Corp.
|
Jun 22, 2022 03:48PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
4
|
Resverlogix Corp.
|
Jun 22, 2022 04:39PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
2
|
Resverlogix Corp.
|
Jun 22, 2022 04:50PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
2
|
Resverlogix Corp.
|
Jun 22, 2022 05:36PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
2
|
Resverlogix Corp.
|
Jun 22, 2022 06:56PM
|
|
Re: Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders
|
3
|
Resverlogix Corp.
|
Jun 20, 2023 11:43PM
|
|
Re: Resverlogix Announces Warrant Repricing and One-Year Extension
|
6
|
Resverlogix Corp.
|
Jun 29, 2023 09:56PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 01:34PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 02:41PM
|
